Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Costantino Errani250 enrolled

Overview

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Bone Metastases

Interventions

AnalysisOTHER

Analysis and review of imaging and clinical data

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years * Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases * Availability of imaging and clinical data * Availability of at least one follow-up during the last 12 months form diagnosis Exclusion Criteria: * At least one inclusion creteria not met

Locations (1)

IRCCS Istituto Ortopedico Rizzoli

Bologna, Emilia-Romagna, Italy

RECRUITING

Outcomes

Primary Outcomes

Creation a dataset of clinical data and diagnostic images

Creation a dataset of clinical data and diagnostic images, called RAW, relating to patients suffering from metastatic bone cancer that will be used by the unit UNICH to create innovative models for fracture risk prediction and of life expectancy based on various patient clinical parameters.

Time frame: At baseline (Day 0)

Central Contacts

Costantino Errani, MD

CONTACT

0516366 costantino.errani@ior.it

Roberta Laranga, PhD

CONTACT

051636 roberta.laranga@ior.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.